Akang health

company

About

Akang health is an operation and management organization of prescription drugs for chronic diseases.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
¥200M
Industries
Health Care,Medical,Pharmaceutical
Number Of Employee
1 - 10
Operating Status
Active

Akon health is an operation and management organization of prescription drugs for chronic diseases, which integrates prescription drug management, chronic disease management, hospital prescription circulation, e-commerce operation, and out-of-hospital prescription increment. It focuses on providing pharmaceutical service and care for patients with chronic diseases who leave the hospital, and providing channel expansion, product increment, and patient data management of out-of-hospital prescription drugs for pharmaceutical enterprises.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥200M
Akang health has raised a total of ¥200M in funding over 2 rounds. Their latest funding was raised on Mar 17, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 17, 2021 Series B ¥200M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
Akang health is funded by 3 investors. Shenzhen Weizi Wealth Fund and Nanjing Bofu Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Shenzhen Weizi Wealth Fund Series B
Nanjing Bofu Investment Series B
China Science and Technology Innovation Series B